Innovative treatment for extrapulmonary benefits in COPD: effects and mechanisms of supramaximal High-Intensity Training

COPD-HIT aims to explore and enhance extrapulmonary treatments for COPD through high-intensity training, focusing on brain health, muscle quality, and cardiac function via innovative research methods.

Subsidie
€ 1.490.438
2023

Projectdetails

Introduction

Given the substantial negative impact of extrapulmonary manifestations on vital clinical outcomes, including mortality, the need for new effective treatment modalities beyond the lungs has been highlighted as an urgent challenge in the management of chronic obstructive pulmonary disease (COPD), one of the most common and deadliest diseases of the 21st century.

Project Aim

The aim of COPD-HIT is to pave the way for new understanding of the development and treatment of extrapulmonary manifestations in COPD with a focus on brain health, muscle quality, and cardiac function.

Research Objectives

To do this, I will focus on the following research objectives (RO):

  1. RO1: Determine the effect of supramaximal High-Intensity Training (HIT) on the brain, muscle, and heart.
  2. RO2: Determine how exercise training and inflammation impact the trajectories of neurodegeneration.
  3. RO3: Develop a novel in-vitro model to determine signaling pathways following various loading intensities.

Methodology

To reach these objectives, I aim to conduct high-quality multicenter randomized controlled and experimental trials.

Further, I will lead an international research alliance with access to state-of-the-art research infrastructures and enable a unique interdisciplinary approach to fulfill my goals. This includes:

  • Using advanced measurement techniques for muscle, brain, and cardiorespiratory evaluations.
  • Conducting muscle biopsy analyses.
  • Implementing in-vivo & in-vitro strategies.
  • Combining quantitative and qualitative methods.

Conclusion

Taken together, with COPD-HIT, I am in a strong position to perform an international novel project that will determine how to enable extrapulmonary benefits in COPD in a hitherto unprecedented way.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.490.438
Totale projectbegroting€ 1.490.438

Tijdlijn

Startdatum1-7-2023
Einddatum30-6-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UMEA UNIVERSITETpenvoerder

Land(en)

Sweden

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Regulation of the L-arginine – ADMA – Nitric Oxide (NO) Pathway in the Pulmonary Vascular Response to Hypoxia and its Role for Survival of High-Risk COPD Patients

NO PRESSURE aims to uncover the role of intermittent hypoxaemia in COPD progression and identify high-risk patients through innovative molecular and clinical studies targeting the L-arginine-ADMA-NO pathway.

€ 2.499.927
ERC Consolid...

Understanding the host-environmental interactions across the lifespan determining lung function trajectories and COPD

PredictCOPD aims to identify early-life gene-environment interactions that influence lung health trajectories, with the goal of preventing COPD and associated multimorbidity through targeted interventions.

€ 1.998.319
ERC Consolid...

Dynamic engIneered heart tiSsue to Study intEr-individual susCeptibily and improve Treatment of Heart Failure

DISSECT-HF aims to engineer heart tissue from patient-specific stem cells to uncover common mechanisms of heart failure across different etiologies and improve treatment strategies.

€ 1.998.775
ERC Proof of...

The Mitochondrial Paradox: Embracing Mitohormesis for Improved Metabolic and Aging Health

This project aims to explore endothelial mitohormesis as a novel therapeutic approach to combat obesity and aging-related disorders using a specialized mouse model.

€ 150.000
ERC Starting...

Mending sex differences: Unravelling the female predominance in pulmonary hypertension

This project aims to uncover the mechanisms behind the female predominance in pulmonary hypertension to identify new therapeutic targets and develop selective drug delivery methods for improved treatment.

€ 1.499.999

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

I-HIT: INTELLIGENT HOLOGAIT INTERVENTION TOOLKIT

De I-HIT toolkit ontwikkelt een innovatieve, data-gedreven oplossing met sensortechnologie en Mixed Reality om revalidatie van de onderste extremiteit te verbeteren en versnellen.

€ 206.266
EIC Pathfinder

Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions

CARDIOREPAIR aims to identify and therapeutically target RBM20 mutations in dilated cardiomyopathy using high-throughput genomics and bioengineering to improve heart health outcomes.

€ 4.349.410
Mkb-innovati...

High Throughput Cell contractility system for rapid drug evaluation

Cytocypher en Optics11 ontwikkelen samen een prototype van een high throughput screening systeem voor het functioneel meten van hartspiercellen, ter bevordering van cardiologisch onderzoek.

€ 193.900